New Treatment Option for Androgenetic Alopecia

Reid Waldman, MD, Co-Founder and CEO of Veradermics, discusses the prevalence of androgenetic alopecia-pattern hair loss and the company's investigational treatment candidate.

Waldman
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free